In the analysis of the incidence of adverse effects in patients with leishmaniasis, we found that vomiting and diarrhea were most common in patients treated with miltefosine, and pain at the injection site and abnormalities in aspartate aminotransferase and alanine aminotransferase were most common in patients treated with paromomycin. The gene discussed is GPT; the disease is leishmaniasis.